Inventor · disambiguated record
Thomas Engber
Also filed as: ENGBER THOMAS · ENGBER THOMAS M
2 granted patents·9 pending applications·14 citations·filing 1997–2019
57Inventor score
Files withBIOGEN INT NEUROSCIENCE GMBH2DISARM THERAPEUTICS INC2GALDES ALPHONSE2BUSSIERE THIERRY1CEPHALON INC1
Top patents by PatentIndex Score
11 records- 0186US12083114B2Inhibitors of SARM1 in combination with neuro-protective agentsDISARM THERAPEUTICS INC·Filed 2019·Granted Sep 10, 2024·5 cites·9 claims
- 0262US2008221037A1Methods and compositions for treating disorders involving excitotoxicityGALDES ALPHONSE·Filed 2008·Application pending·0 cites
- 0357US2018011112A1Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the BrainBIOGEN INT NEUROSCIENCE GMBH·Filed 2017·Application pending·0 cites
- 0456US2019094245A1Use of an Anti-Alpha-Synuclein Antibody to Diagnose an Elevated Level of Alpha-Synuclein in the BrainBIOGEN INT NEUROSCIENCE GMBH·Filed 2018·Application pending·0 cites
- 0553US2014295465A1USE OF AN ANTI-alpha-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF alpha-SYNUCLEIN IN THE BRAINWEIHOFEN ANDREAS·Filed 2012·Application pending·0 cites
- 0648US2022072019A1Inhibitors of sarm1 in combination with nad+ or a nad+ precursorDISARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0748US2007254364A1Methods and compositions for treating disorders involving excitotoxicityGALDES ALPHONSE·Filed 2007·Application pending·0 cites
- 0846US6184217B1Use of K-252a derivativeCEPHALON INC·Filed 1997·Granted Feb 6, 2001·9 cites·2 claims
- 0940US2004220096A1Method and compositions for treating dopaminergic and gabanergic disordersCURIS INC·Filed 2003·Application pending·0 cites
- 1037US2015315267A1A method of reducing brain amyloid plaques using anti-ab antibodiesBUSSIERE THIERRY·Filed 2013·Application pending·0 cites
- 1129US2008045926A1Treatment of Conditions Involving Dopaminergic Neuronal Degeneration Using Nogo Receptor AntagonistsRELTON JANE K·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Engber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →